NewsRx

Search our medical news database

Pennsylvania State University

HBV reverse transcriptase and epsilon RNA sequences are required for interaction

Published in Health Insurance Law Weekly, April 16th, 2006

According to a study from the United States, hepatitis B virus (HBV) reverse transcriptase and epsilon RNA sequences are required for specific interaction in vitro.

"Initiation of reverse transcription and nucleocapsid assembly in HBV depends on the specific recognition of an RNA signal (the packaging signal, E) on the pregenomic RNA by the viral reverse transcriptase (RT)," wrote J.M. Hu and colleagues, Pennsylvania State University.

The researchers wrote, "Using an in vitro reconstitution system whereby the cellular heat shock protein 90 chaperone system activates recombinant HBV RT for specific E binding, we have defined the protein and RNA...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Insurance Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook